PharmEasy
PharmEasy’s parent API Holdings postpones IPO citing market conditions
Aknamed acquired by PharmEasy at $144 Mn valuation; co-founders exit
PharmEasy raises $350 Mn round led by Prosus and TPG; enters unicorn club